These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 11740983)

  • 1. Long-term treatment with citalopram in patients with highly recurrent forms of unipolar depression.
    Franchini L; Spagnolo C; Rampoldi R; Zanardi R; Smeraldi E
    Psychiatry Res; 2001 Dec; 105(1-2):129-33. PubMed ID: 11740983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Citalopram in the maintenance treatment of major depressive disorder.
    Sonawalla SB
    J Clin Psychiatry; 2001 Dec; 62(12):993. PubMed ID: 11780882
    [No Abstract]   [Full Text] [Related]  

  • 3. Two-year maintenance treatment with citalopram, 20 mg, in unipolar subjects with high recurrence rate.
    Franchini L; Zanardi R; Gasperini M; Smeraldi E
    J Clin Psychiatry; 1999 Dec; 60(12):861-5. PubMed ID: 10665634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Citalopram 20 mg, citalopram 40 mg and placebo in the prevention of relapse of major depression.
    Montgomery SA; Rasmussen JG
    Int Clin Psychopharmacol; 1992 Jun; 6 Suppl 5():71-3. PubMed ID: 1431025
    [No Abstract]   [Full Text] [Related]  

  • 5. A randomized controlled trial of antidepressant continuation for major depression following traumatic brain injury.
    Rapoport MJ; Mitchell RA; McCullagh S; Herrmann N; Chan F; Kiss A; Feinstein A; Lanctôt KL
    J Clin Psychiatry; 2010 Sep; 71(9):1125-30. PubMed ID: 20441723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is prior course of illness relevant to acute or longer-term outcomes in depressed out-patients? A STAR*D report.
    Rush AJ; Wisniewski SR; Zisook S; Fava M; Sung SC; Haley CL; Chan HN; Gilmer WS; Warden D; Nierenberg AA; Balasubramani GK; Gaynes BN; Trivedi MH; Hollon SD
    Psychol Med; 2012 Jun; 42(6):1131-49. PubMed ID: 22008447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quetiapine as combination treatment with citalopram in unipolar depression with prominent somatic symptoms: a randomised, double-blind, placebo-controlled pilot study.
    Quante A; Regen F; Schindler F; Volkmer K; Severus E; Urbanek C; Luborzewski A; Roepke S; Anghelescu I
    Psychiatr Danub; 2013 Sep; 25(3):214-20. PubMed ID: 24048387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and tolerability of escitalopram versus citalopram in major depressive disorder: a 6-week, multicenter, prospective, randomized, double-blind, active-controlled study in adult outpatients.
    Yevtushenko VY; Belous AI; Yevtushenko YG; Gusinin SE; Buzik OJ; Agibalova TV
    Clin Ther; 2007 Nov; 29(11):2319-32. PubMed ID: 18158074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single i.v. ketamine augmentation of newly initiated escitalopram for major depression: results from a randomized, placebo-controlled 4-week study.
    Hu YD; Xiang YT; Fang JX; Zu S; Sha S; Shi H; Ungvari GS; Correll CU; Chiu HF; Xue Y; Tian TF; Wu AS; Ma X; Wang G
    Psychol Med; 2016 Feb; 46(3):623-35. PubMed ID: 26478208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A double-blind, placebo-controlled treatment trial of citalopram for major depressive disorder in older patients with heart failure: the relevance of the placebo effect and psychological symptoms.
    Fraguas R; da Silva Telles RM; Alves TC; Andrei AM; Rays J; Iosifescu DV; Wajngarten M
    Contemp Clin Trials; 2009 May; 30(3):205-11. PubMed ID: 19470312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selecting among second-step antidepressant medication monotherapies: predictive value of clinical, demographic, or first-step treatment features.
    Rush AJ; Wisniewski SR; Warden D; Luther JF; Davis LL; Fava M; Nierenberg AA; Trivedi MH
    Arch Gen Psychiatry; 2008 Aug; 65(8):870-80. PubMed ID: 18678792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First episode of major depressive disorder and vascular factors in coronary artery disease patients: Baseline characteristics and response to antidepressant treatment in the CREATE trial.
    Habra ME; Baker B; Frasure-Smith N; Swenson JR; Koszycki D; Butler G; van Zyl LT; Lespérance F
    J Psychosom Res; 2010 Aug; 69(2):133-41. PubMed ID: 20624511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Efficacy of escitalopram and severity of depression: new data].
    Spadone C
    Encephale; 2009 Dec; 35(6):577-85. PubMed ID: 20004289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Value of tianeptine in treating major recurrent unipolar depression. Study versus placebo for 16 1/2 months of treatment].
    Daléry J; Dagens-Lafant V; De Bodinat C
    Encephale; 1997; 23(1):56-64. PubMed ID: 9172969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and efficacy of oral escitalopram as continuation treatment of intravenous citalopram in patients with major depressive disorder.
    Schmitt L; Tonnoir B; Arbus C
    Neuropsychobiology; 2006; 54(4):201-7. PubMed ID: 17337913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized, double-blind, 24-week study of escitalopram (10 mg/day) versus citalopram (20 mg/day) in primary care patients with major depressive disorder.
    Colonna L; Andersen HF; Reines EH
    Curr Med Res Opin; 2005 Oct; 21(10):1659-68. PubMed ID: 16238906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An evaluation of the quick inventory of depressive symptomatology and the hamilton rating scale for depression: a sequenced treatment alternatives to relieve depression trial report.
    Rush AJ; Bernstein IH; Trivedi MH; Carmody TJ; Wisniewski S; Mundt JC; Shores-Wilson K; Biggs MM; Woo A; Nierenberg AA; Fava M
    Biol Psychiatry; 2006 Mar; 59(6):493-501. PubMed ID: 16199008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Severe forms of depression: the efficacy of escitalopram].
    Spadone C
    Encephale; 2009 Apr; 35(2):152-9. PubMed ID: 19393384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical efficacy and achievement of a complete remission in depression: increasing interest in treatment with escitalopram].
    Favré P
    Encephale; 2012 Feb; 38(1):86-96. PubMed ID: 22381728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Citalopram (Cipramil) in monotherapy of depressed outpatients].
    Landowski J
    Psychiatr Pol; 2000; 34(3 Suppl):1-8. PubMed ID: 11055187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.